{"eu_number": "EU-1-16-1158", "parse_date": "2022-11-27 10:56:47.555452", "decisions": [{"filename": "EU-1-16-1158_h_dec_0.pdf", "eu_aut_date": "2017-04-01 00:00:00", "eu_brand_name_initial": "AFSTYLA", "active_substance": "lonoctocog alfa", "eu_nas": true, "eu_atmp": false, "eu_od_initial": "OD Not Found", "eu_mah_initial": "CSL Behring GmbH", "eu_aut_type_initial": "CMA Not Found", "status": "Parsed"}, {"filename": "EU-1-16-1158_h_dec_1.pdf", "eu_aut_date": "2019-02-25 00:00:00", "eu_brand_name_initial": "AFSTYLA", "active_substance": "lonoctocog alfa", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "OD Not Found", "eu_mah_initial": "CSL Behring GmbH", "eu_aut_type_initial": "CMA Not Found", "status": "Parsed"}, {"filename": "EU-1-16-1158_h_dec_2.pdf", "eu_aut_date": "2020-03-04 00:00:00", "eu_brand_name_initial": "AFSTYLA", "active_substance": "lonoctocog alfa", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "OD Not Found", "eu_mah_initial": "CSL Behring GmbH", "eu_aut_type_initial": "CMA Not Found", "status": "Parsed"}, {"filename": "EU-1-16-1158_h_dec_3.pdf", "eu_aut_date": "2021-08-20 00:00:00", "eu_brand_name_initial": "AFSTYLA", "active_substance": "lonoctocog alfa", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "OD Not Found", "eu_mah_initial": "CSL Behring GmbH", "eu_aut_type_initial": "CMA Not Found", "status": "Parsed"}], "annexes": [{"pdf_file": "EU-1-16-1158_h_anx_0.pdf", "xml_file": "EU-1-16-1158_h_anx_0.xml", "is_initial": true, "creation_date": "D:20161125103440+01'00'", "modification_date": "D:20161125103528+01'00'", "initial_type_of_eu_authorization": "standard", "eu_type_of_medicine": "small molecule", "therapeutic_indications": "treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).\n\n afstyla can be used for all age groups.\n"}, {"pdf_file": "EU-1-16-1158_h_anx_1.pdf", "xml_file": "EU-1-16-1158_h_anx_1.xml", "is_initial": false, "creation_date": "D:20181008095108+02'00'", "modification_date": "D:20181030164133+01'00'"}, {"pdf_file": "EU-1-16-1158_h_anx_2.pdf", "xml_file": "EU-1-16-1158_h_anx_2.xml", "is_initial": false, "creation_date": "D:20191015154355Z00'00'", "modification_date": "D:20191015114355-04'00'"}, {"pdf_file": "EU-1-16-1158_h_anx_3.pdf", "xml_file": "EU-1-16-1158_h_anx_3.xml", "is_initial": false, "creation_date": "D:20210715151103+02'00'", "modification_date": "D:20210720111736+02'00'"}], "epars": [{"filename": "EU-1-16-1158_h_public-assessment-report", "ema_procedure_start_initial": "4/12/2015", "chmp_opinion_date": "10/11/2016", "eu_legal_basis": ["article 8.3"], "eu_prime_initial": "no", "ema_rapp": "jan mueller-berghaus", "ema_corapp": "tuomo lapvetel\u00e4inen", "ema_reexamination": "yes", "eu_accel_assess_g": "no"}], "omars": []}